Navigation Links
Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting

tatements. Acorda Therapeutics disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About Acorda Therapeutics

Acorda Therapeutics is a biotechnology company developing therapies for SCI, MS and related nervous system disorders. The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Contact

Acorda Therapeutics
Erica Wishner, 914-347-4300 ext. 162
ewishner@acorda.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
2. Acorda Therapeutics to Host Analyst and Investor Reception
3. Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Acorda Therapeutics Presents Fampridine Data ACTRIMS Meeting
(Date:9/12/2014)... 12, 2014 Sepsis is a life ... worldwide.  Education and awareness are fundamental to improving ... marks Sepsis Awareness Month and September 13 th ... Sepsis Alliance, "Sepsis, the body,s toxic reaction to ... every year, and thousands more are left with ...
(Date:9/11/2014)... , September 11, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/lqkmlx/radio_frequency ) has announced the ... Identification (RFID) Market in Healthcare (Tags, ... Industry Analysis, Size, Share, Growth, Trends ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
(Date:9/11/2014)... , Sept. 11, 2014 Array BioPharma Inc. ... focused on the discovery, development and commercialization of ... cancer, today announced the appointment of Victor ... Sandor will be responsible for leading clinical, medical ... portfolio, including binimetinib, a MEK inhibitor in Phase ...
Breaking Medicine Technology:Nanomix Supports Sepsis Awareness 2Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 2Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 3Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 2Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 3Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 4
(Date:9/14/2014)... September 14, 2014 Proper oral care ... from Butte, Mont., found a way to teach children ... patent-pending B LITE toothbrush encourages an effective brushing habit ... full two minutes without overbrushing, eliminating guesswork and promoting ... easy to use, suitable for all children, and producible ...
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable ... host suppliers carefully, the site has announced that ... the Best WordPress Hosting suppliers in the current ... top web hosting provider, and the company’s reputation ... hosting provider known for its flexible hosting packages, ...
(Date:9/14/2014)... 2014 UWDress.com, is an internationally well-known ... recently announced its new range of cocktail dresses ... more benefits to worldwide ladies, the company is also ... wedding outfits, blue evening gowns, black formal gowns and ... percent off. , The company’s senior spokesman says, ...
(Date:9/13/2014)... 2014 East Vancouver chiropractor from ... chiropractic clinic, has recently published a blog busting ... blog on the topic, Dr Shervin Ranjbar has ... that people have regarding this branch of medicine. ... of a chiropractor and that of a physiotherapist, ...
(Date:9/13/2014)... (HealthDay News) -- Researchers say they,ve tracked specific activity ... hasn,t been clear whether imagination and memory were distinct ... Provo, Utah, decided to explore the issue. "I ... future and imagining myself in the future, and I ... co-author Stefania Ashby said in a university news release. ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:East Vancouver Chiropractor Releases Blog to Bust Myths about Chiropractic Medicine 2Health News:Scientists Watch Imagination at Work in the Brain 2
... Tender Offer Connected with Previously Announced Plans to Separate Medical ... Technology and Funeral Services Businesses, ... ) (the "Company") announced today that it has,commenced a cash ... percent Senior Notes due 2009 (CUSIP No. 431573AD6), of which ...
... 29 Orchid Cellmark Inc.,(Nasdaq: ORCH ), a ... its fourth quarter and full year 2007 financial,results on ... and is,hosting a conference call and webcast to discuss ... Management will discuss financial results for the,fourth quarter and ...
... With the State of,Minnesota facing a $935 million ... to ensure that the health and independence of,the ... "On the one hand, legislators are discussing meaningful ... chronic conditions, and on the,other, we expect the ...
... The Board of,Directors of Schering-Plough Corporation (NYSE: ... for Ian McInnes, Ph.D., to senior vice,president and ... vice,president, Global Supply Chain. The change reflects the ... that now includes operations from,Organon BioSciences N.V., acquired ...
... the disease , , FRIDAY, Feb. 29 (HealthDay News) -- While ... also play a major role in the development of the ... on more than 40,000 twins born in 1958 or earlier, ... risk for chronic bronchitis and that 14 percent of the ...
... Feb. 29 The American people,through the ... and,a consortium of four partners, will assist ... implement HIV/AIDS prevention, malaria and child,survival programs. ... project,will involve district stakeholders, the private sector ...
Cached Medicine News:Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 2Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 3Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 4Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 5Health News:Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008 2Health News:Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain 2Health News:Genetic Factors for Smoking Boost Chronic Bronchitis Risk 2Health News:USAID Implements Behavior Change and Social Marketing Program in Rwanda 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: